News Archive

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM quoted CelLBxHealth plc (AIM: CLBX), a leader in circulating tumor cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology.

CelLBxHealth is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and precision medicine. CelLBxHealth is commercialising the Parsortix system, for the isolation and harvest of intact, living cancer cells from a simple blood sample, together with associated tests for the analysis of these cells.

The account will be led by Paul McManus, Managing Director, alongside Alice Woodings, a Director within the Healthcare team. The team will manage the Company’s ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

Paul McManus, Founder and Managing Director of Walbrook PR, said: “We’re delighted to work with the CelLBxHealth team to support its Financial Communications and Investor Relations. We look forward to supporting CelLBxHealth as they continue to execute their vision to improve outcomes for cancer patients through liquid biopsy blood tests."

 

For further information please contact:

Paul McManus

Tel: 020 7933 8780

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

About Walbrook PR: www.walbrookpr.com

Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM quoted companies.

Walbrook PR is ranked #2 in the AIM Adviser Rankings guide and is ranked in the top ten PR advisers by total number of Stock Market quoted clients. Walbrook acts for 40 listed companies (mainly AIM) across a wide mix of sectors and is the clear market leader by number of quoted companies in the Healthcare sector.

Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM quoted companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.